Mapfre (MAP)

Real-time derived


Symbol		Exchange		Currency
MAP	·	Derived	·	EUR	Real-time
MAP	·	Madrid	·	EUR	Delayed
MAPe	·	BATS Europe	·	EUR	Delayed
MPFRY	·	OTC Markets	·	USD	Delayed
0NQ2	·	London	·	EUR	Real-time
1MAP	·	Milan	·	EUR	Real-time
MAP	·	Frankfurt	·	EUR	Delayed
MAP	·	TradeGate	·	EUR	Delayed
MAP	·	Vienna	·	EUR	Real-time

Currency in EUR

MAP Pro Research

3.824

+0.054(+1.43%)

Closed·13/02

Fair Value

Unlock Value

Day's Range

3.792

3.906

52 wk Range

2.340

4.332

Mapfre (MAP) Income Statement & Profits

Assess the Mapfre Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

19,839.9

25,243.51

28,985

29,243.7

23,532.51

	Total Revenues Growth
	Premiums and Annuity Revenues
	Total Interest And Dividend Income
	Other Revenues

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.18%	+27.24%	+14.82%	+0.89%	-19.53%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	17,464.1	22,717.2	24,781	25,512.6	20,204.47
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	992	168.8	649.1	788.5	636.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,383.8	2,357.51	3,554.9	2,942.6	2,691.93

Total Operating Expenses

aa.aa

18,434.5

24,560

26,683.6

26,516.6

21,007.78

	Operating Expenses Growth
	Policy Benefits
	Policy Acquisition/Underwriting Costs, Total
	Other Operating Expenses, Total

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.93%	+33.23%	+8.65%	-0.63%	-20.78%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	12,865.4	15,402.1	16,903.8	16,456.7	14,059.95
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,611	4,914.8	5,358.3	5,577.2	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	958.1	4,243.1	4,421.5	4,482.7	6,947.83

Operating Income

aa.aa

1,405.4

683.51

2,301.4

2,727.1

2,524.73

Operating Income Growth

aa.aa

-1.85%

-51.37%

+236.7%

+18.5%

-7.42%

EBIT Margin %

aa.aa

7.08%

2.71%

7.94%

9.33%

10.73%

Interest Expense, Total

aa.aa

-83.2

-149.3

-154.4

-158.4

Other Non Operating Expenses, Total

aa.aa

16.3

634.29

-472.7

-459.9

EBT, Excl. Unusual Items

aa.aa

1,338.5

1,168.5

1,674.3

2,108.8

2,524.73

EBT, Excl. Unusual Items Growth

aa.aa

-1.18%

-12.7%

+43.29%

+25.95%

+19.72%

Merger & Restructuring Charges

aa.aa

Gain (Loss) On Sale Of Assets

aa.aa

32.2

118.5

57.5

87.9

Other Unusual Items, Total

aa.aa

-15.6

-17

-9.1

-6.9

EBT, Incl. Unusual Items

aa.aa

1,355.1

1,270

1,647.7

2,099.8

2,524.73

EBT, Incl. Unusual Items Growth

aa.aa

+21.15%

-6.28%

+29.74%

+27.44%

+20.24%

Income Tax Expense

aa.aa

319.5

296.3

381.1

512.5

727.52

Net Income to Company

aa.aa

1,035.6

973.7

1,266.6

1,587.3

1,797.21

Minority Interest

aa.aa

-270.4

-410.1

-589.4

-619.8

-664.66

Net Income

aa.aa

765.2

563.6

677.2

967.5

1,132.56

Net Income Growth

aa.aa

+45.34%

-26.35%

+20.16%

+42.87%

+17.06%

Net Income Margin %

aa.aa

3.86%

2.23%

2.34%

3.31%

4.81%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

765.2

563.6

677.2

967.5

1,132.56

Basic EPS - Continuing Operations

aa.aa

0.25

0.18

0.22

0.32

0.37

Basic EPS - Continuing Operations Growth

aa.aa

+44.79%

-26.2%

+19.78%

+42.72%

+17.31%

Diluted EPS - Continuing Operations

aa.aa

0.25

0.18

0.22

0.32

0.37

Diluted EPS - Continuing Operations Growth

aa.aa

+44.79%

-26.2%

+19.78%

+42.72%

+17.31%

Basic Weighted Average Shares Outstanding

aa.aa

3,060.8

3,054.6

3,064.2

3,067.4

3,060.96

Diluted Weighted Average Shares Outstanding

aa.aa

3,060.8

3,054.6

3,064.2

3,067.4

3,060.96

Dividend Per Share

aa.aa

0.15

0.16

Dividend Per Share Growth

aa.aa

+16.01%

-0.96%

+3.66%

+6.65%

EBITDA

aa.aa

1,510.3

820.21

2,413.7

2,839.4

2,637.03

EBITDA Growth

aa.aa

-3.48%

-45.69%

+194.28%

+17.64%

-7.13%

EBITDA Margin %

aa.aa

7.61%

3.25%

8.33%

9.71%

11.21%

EBIT

aa.aa

1,405.4

683.51

2,301.4

2,727.1

2,524.73

* In Millions of EUR (except for per share items)

FAQ

What was Mapfre’s net income for the year?

For the full year, Mapfre reported net income of 1,132.555.

How much net income did Mapfre post in the last quarter?

In the most recent quarter, Mapfre (MAP) posted net income of 303.56.

What was Mapfre’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 718.606.

What was the quarter-over-quarter change in EBITDA for Mapfre?

EBITDA changed by 3,853.816% compared to the last quarter.

What is Mapfre’s most recent net income margin?

Net income margin based on recent financials is 6.872%.

What is Mapfre’s most recent EBIT margin?

Mapfre reported an EBIT margin of 15.632% based on current figures.

FTSE 100

10,446.35

+43.91

+0.42%

DAX

24,914.88

+62.19

+0.25%

Euro Stoxx 50

5,985.23

-26.06

-0.43%

S&P 500

6,836.17

+3.41

+0.05%

Nikkei 225

56,941.97

-697.87

-1.21%

Dow Jones

49,500.93

+48.95

+0.10%

FTSE 100 Futures

10,404.50

+39.5

+0.38%

Market Movers

Name	Last	Chg. %	Vol.
Lloyds Banking	100.40	-1.95%	473.65M
NatWest Group	580.20	-2.49%	82.21M
Shell	2,872.5	-0.54%	21.91M
Relx	2,257.00	+9.99%	19.88M
Unilever	5,432.0	+1.44%	9.05M
Reckitt Benckiser	6,468.0	+1.16%	7.26M
AstraZeneca	15,118.0	+1.42%	5.90M

Name	Last	Chg. %	Vol.
Inseego	10.23	+582.00%	0.00
Gl Events	33.20	+59.23%	0.00
Helium One	0.7800	+43.12%	586.92M
Physiomics	0.650	+30.00%	31.30M
Kendrick Resources	1.40	+27.27%	15.15M
abrdn Property	2.35	+25.00%	166.85K
Altona Rare Earths	2.30	+19.17%	44.84M

Name	Last	Chg. %	Vol.
SkinBioTherapeutics	12.38	-36.56%	108.77M
Jade Road Investments	0.80	-35.10%	600.00
Schweizerische Nationalbank	3,490.00	-23.46%	0.00
Marley Spoon	0.17	-22.94%	545.00
Synthomer	19.16	-21.48%	9.35M
Tern PLC	0.40	-18.46%	4.62M
Kendrion	15.90	-17.62%	0.00

Trending Stocks

Name	Last	Chg. %	Vol.
Rolls-Royce Holdings	1,271.00	+3.67%	33.83M
AstraZeneca	15,118.0	+1.42%	5.90M
Relx	2,257.00	+9.99%	19.88M
Barclays	454.00	-2.07%	61.82M
Lloyds Banking	100.40	-1.95%	473.65M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aa Aaaaaa	461.00	+41.90%	654.16
Aa Aaaaaa Aa	1,577.00	+41.04%	2,224.20
Aaaaaa	2,132.0	+35.87%	2,896.7
Aaaaaa Aaaaaaaa	807.40	+32.62%	1,070.77
Aaaa A A	2,165.00	+31.75%	2,852.39
Aaaaa Aaaaaaaaaa A	2,257.00	+31.10%	2,958.93
Aaaaaa Aaaa	3,436.00	+29.78%	4,459.24

Name	Last	Upside	Fair Value
Aa Aa Aaaaaa	461.00	+41.90%	654.16
Aa Aaaaaa Aa	1,577.00	+41.04%	2,224.20
Aaaaaa	2,132.0	+35.87%	2,896.7
Aaaaaa Aaaaaaaa	807.40	+32.62%	1,070.77
Aaaa A A	2,165.00	+31.75%	2,852.39
Aaaaa Aaaaaaaaaa A	2,257.00	+31.10%	2,958.93
Aaaaaa Aaaa	3,436.00	+29.78%	4,459.24

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Mapfre (MAP)

Mapfre (MAP) Income Statement & Profits

FAQ

What was Mapfre’s net income for the year?

How much net income did Mapfre post in the last quarter?

What was Mapfre’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Mapfre?

What is Mapfre’s most recent net income margin?

What is Mapfre’s most recent EBIT margin?

Trending Stocks